CC
BSX icon

Callan Capital’s Boston Scientific BSX Stock Holding History

Callan Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$474K Buy
4,695
+462
+11% +$46.5K 0.04% 219
2024
Q4 		$378K Buy
4,233
+592
+16% +$52.1K 0.03% 221
2024
Q3 		$305K Buy
3,641
+146
+4% +$11.5K 0.02% 258
2024
Q2 		$269K Buy
3,495
+484
+16% +$35.4K 0.02% 251
2024
Q1 		$206K Buy
+3,011
New +$194K 0.02% 273

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Callan Capital's BSX Position: Q1 2025 in Review

Callan Capital increased its Boston Scientific (BSX) stake by 11% in Q1 2025, buying an estimated $46.5K and bringing the position to 4,695 shares worth $474K. The position accounts for 0.04% of the portfolio, ranked #219.

Callan Capital first reported a position in BSX in Q1 2024 and has held it in 5 quarters since. 1,647 funds tracked by Wall St. Rank hold BSX as of Q1 2025.

  • Callan Capital held 4,695 shares of Boston Scientific worth $474K as of Q1 2025.
  • Callan Capital bought 462 Boston Scientific shares in Q1 2025, an estimated $46.5K.
  • Boston Scientific made up 0.04% of Callan Capital's portfolio in Q1 2025, its #219 holding.
  • Callan Capital first reported a position in Boston Scientific in Q1 2024 and has held it in 5 quarters since.
  • 1,647 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2025.

Based on Callan Capital's 13F filing for Q1 2025, filed 29 Apr 2025.